GEJ Signet Ring Cell with skip lesion to mid Esophagus post neoadjuvant
preprint
OA: closed
Abstract
Signet ring cells consider one of the rare diagnosis that can be managed among the oncological diseases.Confined on poor prognosis and advancement of their stage.Not seems to be affected properly with the chemotherapy. And still the surgical option is the best in operable case to decrease the burden
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00